Antihistaminergics and inverse agonism: Potential therapeutic applications
Open Access
- 5 September 2013
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 715 (1-3), 26-32
- https://doi.org/10.1016/j.ejphar.2013.06.027
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Expression of a G Protein-coupled Receptor (GPCR) Leads to Attenuation of Signaling by Other GPCRsOnline Journal of Public Health Informatics, 2010
- Molecular and biochemical pharmacology of the histamine H4 receptorBritish Journal of Pharmacology, 2009
- Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signalingEuropean Journal of Pharmacology, 2008
- Mepyramine, a Histamine H1 Receptor Inverse Agonist, Binds Preferentially to a G Protein-coupled Form of the Receptor and Sequesters G ProteinPublished by Elsevier BV ,2004
- The Cubic Ternary Complex Receptor-Occupancy Model III. Resurrecting EfficacyJournal of Theoretical Biology, 1996
- The Cubic Ternary Complex Receptor–Occupancy Model II. Understanding Apparent AffinityJournal of Theoretical Biology, 1996
- The Cubic Ternary Complex Receptor–Occupancy Model I. Model DescriptionJournal of Theoretical Biology, 1996
- Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuityTrends in Pharmacological Sciences, 1995
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptorsJournal of Neural Transmission, 1993
- The influence of histamine on precursors of granulocytic leukocytes in murine bone marrowLife Sciences, 1988